Hypomagnesemia and Chondrocalcinosis in Bartter’s and Gitelman’s Syndrome: Review of the Pathogenetic Mechanisms

Editorials| November 15 2000 Hypomagnesemia and Chondrocalcinosis in Bartter’s and Gitelman’s Syndrome: Review of the Pathogenetic Mechanisms Subject Area: Nephrology Lorenzo Calò; Lorenzo Calò aDepartments of Clinical and Experimental Medicine, Clinica Medica 4, and Search for other works by this author on: This Site PubMed Google Scholar Leonardo Punzi; Leonardo Punzi bMedical and Surgical Sciences, Division of Rheumatology, University of Padova, Italy Search for other works by this author on: This Site PubMed Google Scholar Andrea Semplicini Andrea Semplicini aDepartments of Clinical and Experimental Medicine, Clinica Medica 4, and Search for other works by this author on: This Site PubMed Google Scholar Am J Nephrol (2000) 20 (5): 347–350. https://doi.org/10.1159/000013614 Article history Published Online: November 15 2000 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Lorenzo Calò, Leonardo Punzi, Andrea Semplicini; Hypomagnesemia and Chondrocalcinosis in Bartter’s and Gitelman’s Syndrome: Review of the Pathogenetic Mechanisms. Am J Nephrol 1 October 2000; 20 (5): 347–350. https://doi.org/10.1159/000013614 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsAmerican Journal of Nephrology Search Advanced Search This content is only available via PDF. © 2000 S. Karger AG, Basel2000Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Article PDF first page preview Close Modal You do not currently have access to this content.